文献速递先天性心脏病外科

推动有效诊疗与赋能探索:应对成人先天性心脏病晚期心力衰竭的难题

Enabling effective care, empowering discovery: Tackling the tough questions about advanced heart failure in adult congenital heart disease.
PubMed 文献 · J Heart Lung Transplant · 2025-01-01

许多中度或复杂先天性心脏病(CHD)成人会在30至50岁时出现慢性心力衰竭或循环衰竭综合征,死亡风险高;成人先天性心脏病相关心力衰竭(ACHD-HF)病理生理高度异质,但通常有较长的无症状期,代偿机制掩盖进展。2025年ISHLT第45届年会期间,35余名来自北美、欧洲和澳大利亚的成人及儿童心脏科医生、外科医生等参会,讨论研究、教育和患者倡导优先事项,支持在ISHLT下建立ACHD-HF专业社区。

要点

  • ACHD-HF常于30至50岁显现,死亡风险高,因代偿机制难以早期识别。
  • 诊疗碎片化、专科资源有限和知识缺口导致晚期治疗转诊延迟。
  • 移植和机械循环支持在ACHD患者中可获良好结局,但当代选择实践使该人群治疗不足。

核心结论

  • ACHD-HF患者因无症状期长、诊疗碎片化和知识缺口而转诊延迟,导致死亡超额,尤其在移植背景下。
  • 移植和机械循环支持在ACHD患者中可获良好结局,但当代选择实践使该人群治疗不足。
  • 会议广泛支持在ISHLT下建立ACHD-HF专业社区,以协作解决知识缺口、推进诊疗和改善结局。

研究设计与样本

  • 2025年ISHLT第45届年会期间在波士顿召开会议,35余名来自北美、欧洲和澳大利亚的成人及儿童心脏科医生、外科医生、高级实践提供者、研究人员和学员参会。

主要发现

  • 许多中度或复杂CHD成人会在30、40或50岁时出现慢性心力衰竭或循环衰竭综合征,死亡风险高。
  • ACHD-HF病理生理高度异质,通常以较长的无症状期为特征,慢性代偿机制掩盖疾病进展,难以及时识别严重程度。
  • 诊疗碎片化、专科资源有限和持续知识缺口加剧临床挑战,导致晚期治疗转诊延迟,尤其在移植背景下造成超额死亡。
  • 移植和机械循环支持在ACHD患者中可获良好结局,但当代选择实践使该人群治疗不足。
  • 参会者分享研究、教育和患者倡导优先事项意见,广泛支持在ISHLT下建立ACHD-HF专业社区。

临床怎么用

  • 对中度或复杂CHD成人应警惕30至50岁出现慢性心力衰竭或循环衰竭综合征,注意无症状期代偿机制掩盖进展。
  • 应关注诊疗碎片化、专科资源有限和知识缺口导致的晚期治疗转诊延迟,尤其移植背景下超额死亡风险。
  • 移植和机械循环支持在ACHD患者中可获良好结局,但需审视当代选择实践以避免治疗不足。
  • 可借助ISHLT下ACHD-HF专业社区协作解决知识缺口、推进诊疗和改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many adults with moderate or complex congenital heart disease (CHD) develop chronic heart or circulatory failure syndromes, often becoming clinically apparent in their 30 s, 40 s, or 50 s and carrying a high risk of mortality. Although the pathophysiology of adult congenital heart disease-related heart failure (ACHD-HF) is highly heterogeneous, it is typically characterized by a prolonged pre-symptomatic phase. During this time, chronic compensatory mechanisms mask disease progression, making the severity of the condition difficult to recognize in a timely manner. This clinical challenge is compounded by fragmented care models, limited specialist resources, and persistent knowledge gaps. Consequently, patients are referred late for advanced therapies, contributing to the excess mortality, particularly in the context of transplant. While it is recognized that excellent outcomes from transplant and mechanical circulatory support options are achievable in adult CHD patients, contemporary selection practices leave the population undertreated. To advance this cause, we convened a meeting at the 2025 International Society for Heart and Lung Transplantation 45th Annual Meeting & Scientific Sessions in Boston, Massachusetts. The meeting brought together more than 35 participants, including adult and pediatric cardiologists, surgeons, advanced practice providers, researchers, and trainees from North America, Europe and Australia. This diverse group shared opinions regarding priorities for research, education and patient advocacy. A widely supported outcome was the development of an ACHD-HF specific professional community under the umbrella of ISHLT. This entity would serve as a collaborative home for those dedicated to addressing the knowledge gaps in ACHD-HF, advancing care, and improving outcomes for this growing and vulnerable population.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Broda CR, Kearney K, Roche SL, et al. Enabling effective care, empowering discovery: Tackling the tough questions about advanced heart failure in adult congenital heart disease. J Heart Lung Transplant. 2025. PMID: 40947172. doi:10.1016/j.healun.2025.06.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。